Showing results (41-50 of 179) with videos related to
Sort By:
Pageof 18
Cellular and Molecular Life Sciences : CMLS|January 13, 2016
Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugsRichard Bayliss, Jene Choi, Dean A Fennell, et al.Thorax|April 12, 2022
Cytoreductive surgery with hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: a systematic reviewAlan G Dawson, Kudzayi Kutywayo, Seid B Mohammed, et al.Drugs|July 13, 2024
Targeting DNA Damage Response Deficiency in Thoracic CancersAleksandra Bzura, Jake B Spicer, Sean Dulloo, et al.Plos One|February 8, 2011
Gene expression meta-analysis identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancerClaire Grills, Puthen V Jithesh, Jaine Blayney, et al.BMC Cancer|July 22, 2010
Voltage dependent anion channel-1 regulates death receptor mediated apoptosis by enabling cleavage of caspase-8Alex D Chacko, Fabio Liberante, Ian Paul, et al.Nature Clinical Practice. Oncology|January 30, 2008
Advances in the systemic therapy of malignant pleural mesotheliomaDean A Fennell, Giovanni Gaudino, Kenneth J O'Byrne, et al.Plos One|August 30, 2008
Dynamical systems analysis of mitochondrial BAK activation kinetics predicts resistance to BH3 domainsClaire Grills, Nyree Crawford, Alex Chacko, et al.Gut|September 18, 2002
Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cellsA C Okaro, D A Fennell, M Corbo, et al.Cell Reports Methods|April 26, 2024
Analysis of synthetic cellular barcodes in the genome and transcriptome with BARtab and bartoolsHenrietta Holze, Laure Talarmain, Katie A Fennell, et al.British Journal of Cancer|June 10, 2011
Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancerA G Pallis, D A Fennell, E Szutowicz, et al.Pageof 18